{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:42:26Z","timestamp":1792456946960,"version":"4.5.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["001\/2020\/ALC 0033\/2019\/AFJ"],"award-info":[{"award-number":["001\/2020\/ALC 0033\/2019\/AFJ"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015260","name":"Macau University of Science and Technology","doi-asserted-by":"publisher","award":["FRG-22-077-SP"],"award-info":[{"award-number":["FRG-22-077-SP"]}],"id":[{"id":"10.13039\/501100015260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["UID MRC-RFA-UFSP-01\u20132013"],"award-info":[{"award-number":["UID MRC-RFA-UFSP-01\u20132013"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Artemisinin, isolated from the traditional Chinese medicinal plant q\u012bng h\u0101o \u9752\u84bf (<jats:italic>Artemisia annua<\/jats:italic>) and its derivatives are used for treatment of malaria. With treatment failures now being recorded for the derivatives and companion drugs used in artemisinin combination therapies new drug combinations are urgently required. The amino-artemisinins artemiside and artemisone display optimal efficacies <jats:italic>in vitro<\/jats:italic> against asexual and sexual blood stages of the malaria parasite <jats:italic>Plasmodium falciparum<\/jats:italic> and are active against tumour cell lines. In continuing the evolution of combinations of the amino-artemisinins with new drugs, we examine the triterpenoid quinone methide celastrol isolated from the traditional Chinese medicinal plant l\u00e9i g\u014dng t\u00e9ng \u96f7\u516c\u85e4 (<jats:italic>Tripterygium wilfordii<\/jats:italic>). This compound is redox active, and has attracted considerable attention because of potent biological activities against manifold targets. We report that celastrol displays good IC<jats:sub>50<\/jats:sub> activities ranging from 0.50\u20130.82\u00a0\u00b5M against drug-sensitive and resistant asexual blood stage <jats:italic>Pf<\/jats:italic>, and 1.16 and 0.28\u00a0\u00b5M respectively against immature and late stage <jats:italic>Pf<\/jats:italic> NF54 gametocytes. The combinations of celastrol with each of artemisone and methylene blue against asexual blood stage <jats:italic>Pf<\/jats:italic> are additive. Given that celastrol displays promising antitumour properties, we examined its activities alone and in combinations with amino-artemisinins against human liver HepG2 and other cell lines. IC<jats:sub>50<\/jats:sub> values of the amino-artemisinins and celastrol against HepG2 cancer cells ranged from 0.55\u20130.94\u00a0\u00b5M. Whereas the amino-artemisinins displayed notable selectivities (SI &amp;gt; 171) with respect to normal human hepatocytes, in contrast, celastrol displayed no selectivity (SI &amp;lt; 1). The combinations of celastrol with artemiside or artemisone against HepG2 cells are synergistic. Given the promise of celastrol, judiciously designed formulations or structural modifications are recommended for mitigating its toxicity.<\/jats:p>","DOI":"10.3389\/fphar.2022.988748","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T09:47:40Z","timestamp":1662112060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue"],"prefix":"10.3389","volume":"13","author":[{"given":"Jerome P. L.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn-Marie","family":"Birkholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Coertzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Ning","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Coghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Kam Wai","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"Adjalley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1021\/acsmedchemlett.9b00457","article-title":"Antimalarial N(1), N(3)-dialkyldioxonaphthoimidazoliums: Synthesis, biological activity, and structure-activity relationships","volume":"11","author":"Ahenkorah","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1128\/AAC.49.11.4592-4597.2005","article-title":"In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins","volume":"49","author":"Akoachere","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"107706","DOI":"10.1016\/j.pharmthera.2020.107706","article-title":"Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing","volume":"216","author":"Augustin","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom11010056","article-title":"Design, synthesis and in vitro investigation of novel basic celastrol carboxamides as bio-inspired leishmanicidal agents endowed with inhibitory activity against leishmania Hsp90","volume":"11","author":"Bassanini","year":"2021","journal-title":"Biomolecules"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/AAC.00773-07","article-title":"Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum","volume":"52","author":"Buchholz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41598-019-57312-y","article-title":"Metabolomics reveals that cysteine metabolism plays a role in celastrol-induced mitochondrial apoptosis in HL-60 and NB-4 cells","volume":"10","author":"Chen","year":"2020","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fphar.2018.00104","article-title":"A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e02214","DOI":"10.1128\/AAC.02214-17","article-title":"Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in Plasmodium falciparum transmissible gametocyte stages","volume":"62","author":"Coertzen","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113676","DOI":"10.1016\/j.ejmech.2021.113676","article-title":"Synthesis, computational docking and biological evaluation of celastrol derivatives as dual inhibitors of SERCA and P-glycoprotein in cancer therapy","volume":"224","author":"Coghi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, mechanisms of action and combination therapy of artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev. anti. Infect. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/2141-9248.153609","article-title":"Anticancer effect of AntiMalarial artemisinin compounds","volume":"5","author":"Das","year":"2015","journal-title":"Ann. Med. Health Sci. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.nano.2015.07.010","article-title":"In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells","volume":"11","author":"Dwivedi","year":"2015","journal-title":"Nanomedicine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: A vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcp.2017.03.019","article-title":"Cancer combination therapies with artemisinin-type drugs","volume":"139","author":"Efferth","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1128\/AAC.02975-15","article-title":"The redox cycler plasmodione is a fast-acting antimalarial lead compound with pronounced activity against sexual and early asexual blood-stage parasites","volume":"60","author":"Ehrhardt","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1021\/np9704157","article-title":"Novel quinone methides from Salacia kraussii with in vitro antimalarial activity","volume":"61","author":"Figueiredo","year":"1998","journal-title":"J. Nat. Prod."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","article-title":"Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum","volume":"48","author":"Fivelman","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1021\/acsinfecdis.9b00257","article-title":"Ozonide antimalarials alkylate heme in the malaria parasite Plasmodium falciparum","volume":"5","author":"Giannangelo","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3390\/pharmaceutics13122066","article-title":"The artemiside-artemisox-artemisone-M1 tetrad: Efficacies against blood stage P. Falciparum parasites, DMPK properties, and the case for artemiside","volume":"13","author":"Gibhard","year":"2021","journal-title":"Pharmaceutics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00280-010-1355-4","article-title":"In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents","volume":"67","author":"Gravett","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.yexmp.2019.01.006","article-title":"The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells","volume":"107","author":"Greenshields","year":"2019","journal-title":"Exp. Mol. Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1039\/D1BM00639H","article-title":"Recent progress in nanotechnology-based drug carriers for celastrol delivery","volume":"9","author":"Guo","year":"2021","journal-title":"Biomater. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1128\/AAC.46.5.1510-1515.2002","article-title":"In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob Agents Chemother 46","volume":"46","author":"Gupta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/cmdc.201000225","article-title":"Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: Relationship with flavoenzyme function and antimalarial mechanism of action","volume":"5","author":"Haynes","year":"2010","journal-title":"ChemMedChem"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/cmdc.201200383","article-title":"Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action","volume":"7","author":"Haynes","year":"2012","journal-title":"ChemMedChem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/1871526513666131129155708","article-title":"Considerations on the mechanism of action of artemisinin antimalarials: Part 1--the 'carbon radical' and 'heme' hypotheses","volume":"13","author":"Haynes","year":"2013","journal-title":"Infect. Disord. Drug Targets"},{"key":"B29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/cmdc.201000508","article-title":"Reactions of antimalarial peroxides with each of leucomethylene blue and dihydroflavins: Flavin reductase and the cofactor model exemplified","volume":"6","author":"Haynes","year":"2011","journal-title":"ChemMedChem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/anie.200503071","article-title":"Artemisone--a highly active antimalarial drug of the artemisinin class","volume":"45","author":"Haynes","year":"2006","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/anie.200352343","article-title":"Highly antimalaria-active artemisinin derivatives: Biological activity does not correlate with chemical reactivity","volume":"43","author":"Haynes","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e82962","DOI":"10.1371\/journal.pone.0082962","article-title":"Anticancer properties of distinct antimalarial drug classes","volume":"8","author":"Hooft Van Huijsduijnen","year":"2013","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives: In vitro and in vivo activity, chemosensitization, and mechanisms of action","volume":"14","author":"Hou","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8851","DOI":"10.1038\/s41598-020-65773-9","article-title":"Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo","volume":"10","author":"Huang","year":"2020","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1007\/s11033-020-05669-z","article-title":"Artemisinin and its derivatives: A promising cancer therapy","volume":"47","author":"Kiani","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/cb200539u","article-title":"Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets","volume":"7","author":"Klai\u0107","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"14902","DOI":"10.3390\/molecules190914902","article-title":"1, 4-naphthoquinones: From oxidative damage to cellular and inter-cellular signaling","volume":"19","author":"Klotz","year":"2014","journal-title":"Molecules"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24018\/clinicmed.2022.3.3.202","article-title":"Is artesunate the best partner of gemcitabine in pancreatic cancer?","volume":"3","author":"Koltai","year":"2021","journal-title":"Eur. J. Clin. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.3390\/medsci6010019","article-title":"Artemisinin and its synthetic derivatives as a possible therapy for cancer","volume":"6","author":"Konstat-Korzenny","year":"2018","journal-title":"Med. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3109\/10715762.2013.847527","article-title":"Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides","volume":"47","author":"Kucera","year":"2013","journal-title":"Free Radic. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2174\/1381612825666190902155957","article-title":"Combination therapies of artemisinin and its derivatives as a viable approach for future cancer treatment","volume":"25","author":"Kumar","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1039\/c2ob25229e","article-title":"Exploring the trifluoromenadione core as a template to design antimalarial redox-active agents interacting with glutathione reductase","volume":"10","author":"Lanfranchi","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"B43","volume-title":"Artemisinin-based and other antimalarials: Detailed account of studies by Chinese scientists who discovered and developed them","author":"Li","year":"2017"},{"key":"B44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3389\/fphar.2019.00746","article-title":"Anti-cancer effects of pristimerin and the mechanisms: A critical review","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/med.21751","article-title":"Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol","volume":"41","author":"Lu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/cid\/ciaa628","article-title":"Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia","volume":"73","author":"Mairet-Khedim","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00280-020-04170-5","article-title":"Artemisinin-type drugs for the treatment of hematological malignancies","volume":"87","author":"Mancuso","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1021\/acschembio.6b00666","article-title":"Inhibition of the flavin-dependent monooxygenase siderophore A (SidA) blocks siderophore biosynthesis and Aspergillus fumigatus growth","volume":"11","author":"Mart\u00edn Del Campo","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"6793957","DOI":"10.1155\/2019\/6793957","article-title":"Prooxidative activity of celastrol induces apoptosis, DNA damage, and cell cycle arrest in drug-resistant human colon cancer cells","volume":"2019","author":"Moreira","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B51","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1128\/AAC.01585-07","article-title":"First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone","volume":"52","author":"Nagelschmitz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"751271","DOI":"10.3389\/fonc.2021.751271","article-title":"Artemisinin mediates its tumor-suppressive activity in hepatocellular carcinoma through targeted inhibition of FoxM1","volume":"11","author":"Nandi","year":"2021","journal-title":"Front. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/ph15030360","article-title":"Biological evaluation in resistant cancer cells and study of mechanism of action of arylvinyl-1, 2, 4-trioxanes","volume":"15","author":"Ng","year":"2022","journal-title":"Pharmaceuticals"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/AAC.46.8.2518-2524.2002","article-title":"Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro","volume":"46","author":"Ohrt","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1051\/parasite\/2018021","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of damocles in the path toward malaria elimination","volume":"25","author":"Ouji","year":"2018","journal-title":"Parasite"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-23158-3_20","article-title":"Therapeutic effects and related molecular mechanisms of celastrol, a triterpenoid natural compound and novel HSP90 inhibitor extracted from plants of the celastraceae family","volume-title":"Heat shock protein 90 in human diseases and disordersHeat shock proteins","author":"Peng","year":"2019"},{"key":"B57","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12936-017-1942-5","article-title":"Challenges to replace ACT as first-line drug","volume":"16","author":"Phyo","year":"2017","journal-title":"Malar. J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.yexcr.2015.07.004","article-title":"Artesunate induces apoptosis via a ROS-independent and Bax-mediated intrinsic pathway in HepG2 cells","volume":"336","author":"Qin","year":"2015","journal-title":"Exp. Cell Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/ph15010060","article-title":"The role of the iron protoporphyrins heme and hematin in the antimalarial activity of endoperoxide drugs","volume":"15","author":"Quadros","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12936-015-0718-z","article-title":"Nowhere to hide: Interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination","volume":"14","author":"Reader","year":"2015","journal-title":"Malar. J."},{"key":"B61","doi-asserted-by":"publisher","first-page":"926460","DOI":"10.3389\/fcimb.2022.926460","article-title":"Streamlined and robust stage-specific profiling of gametocytocidal compounds against Plasmodium falciparum","volume":"589","author":"Reader","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1006930","DOI":"10.1371\/journal.ppat.1006930","article-title":"Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites","volume":"14","author":"Rocamora","year":"2018","journal-title":"PLoS Pathog."},{"key":"B63","article-title":"Artemifone, a new anti-malarial artemisinin derivative: Metabolism in vitro in liver microsomes and hepatocyte sandwich cultures of different species including man","author":"Schmeer","year":"2005"},{"key":"B64","doi-asserted-by":"publisher","first-page":"558741","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: A review of useful strategies overcoming its limitation in anticancer application","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/cmdc.201600009","article-title":"Redox polypharmacology as an emerging strategy to combat malarial parasites","volume":"11","author":"Sidorov","year":"2016","journal-title":"ChemMedChem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1128\/AAC.00857-16","article-title":"Endoperoxide drug cross-resistance patterns for Plasmodium falciparum exhibiting an artemisinin delayed-clearance phenotype","volume":"60","author":"Siriwardana","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1128\/AAC.01930-13","article-title":"Potent Plasmodium falciparum gametocytocidal activity of diaminonaphthoquinones, lead antimalarial chemotypes identified in an antimalarial compound screen","volume":"59","author":"Tanaka","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1021\/jm200463z","article-title":"Discovery of novel alkylated (bis)urea and (bis)thiourea polyamine analogues with potent antimalarial activities","volume":"54","author":"Verlinden","year":"2011","journal-title":"J. Med. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/jac\/dkl563","article-title":"Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo","volume":"59","author":"Vivas","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"673209","DOI":"10.3389\/fphar.2021.673209","article-title":"Nanotechnology-based celastrol formulations and their therapeutic applications","volume":"12","author":"Wagh","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e0099021","DOI":"10.1128\/AAC.00990-21","article-title":"Toward new transmission-blocking combination therapies: Pharmacokinetics of 10-amino-artemisinins and 11-aza-artemisinin and comparison with dihydroartemisinin and artemether","volume":"65","author":"Watson","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.pt.2020.05.013","article-title":"Artemisinin resistance': Something new or old? Something of a misnomer?","volume":"36","author":"Wellems","year":"2020","journal-title":"Trends Parasitol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nrd2972","article-title":"New medicines to improve control and contribute to the eradication of malaria","volume":"8","author":"Wells","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"B75","doi-asserted-by":"publisher","first-page":"558894","DOI":"10.3389\/fphar.2020.558894","article-title":"Anti-melanoma activities of artemisone and prenylated amino-artemisinins in combination with known anticancer drugs","volume":"11","author":"Wong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3389\/fchem.2019.00901","article-title":"Optimal 10-aminoartemisinins with potent transmission-blocking capabilities for new artemisinin combination therapies-activities against blood stage P. Falciparum including PfKI3 C580Y mutants and liver stage P. Berghei parasites","volume":"7","author":"Wong","year":"2019","journal-title":"Front. Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/femsre\/fuw037","article-title":"The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread","volume":"41","author":"Woodrow","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"B78","article-title":"World Health organisation","year":"2021"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3390\/molecules23071713","article-title":"Facile preparation of N-glycosylated 10-piperazinyl artemisinin derivatives and evaluation of their antimalarial and cytotoxic activities","volume":"23","author":"Wu","year":"2018","journal-title":"Molecules"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/cmdc.201600011","article-title":"Methylene homologues of artemisone: An unexpected structure-activity relationship and a possible implication for the design of C10-substituted artemisinins","volume":"11","author":"Wu","year":"2016","journal-title":"ChemMedChem"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.2147\/OTT.S313933","article-title":"Celastrol modulates multiple signaling pathways to inhibit proliferation of pancreatic cancer via DDIT3 and ATF3 up-regulation and RRM2 and MCM4 down-regulation","volume":"14","author":"Youns","year":"2021","journal-title":"Onco. Targets. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.988748\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T09:47:47Z","timestamp":1662112067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.988748\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":81,"alternative-id":["10.3389\/fphar.2022.988748"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.988748","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"988748"}}